Gara Jalqabaatti › Dhibee Rakkoo Hir'ina Oofuu
Qorannoo klinikaalii Dhibee Rakkoo Hir'ina Oofuu Ameerikaa Keessatti hirmaatuu
Qorannoo 15 Dhibee Rakkoo Hir'ina Oofuu f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- San Antonio, TXQorannoo 9
- Atlanta, GAQorannoo 9
- Cincinnati, OHQorannoo 9
- Charlotte, NCQorannoo 8
- Miami, FLQorannoo 8
- Orlando, FLQorannoo 7
- Sugar Land, TXQorannoo 7
- Austin, TXQorannoo 7
- Columbia, SCQorannoo 7
- Brandon, FLQorannoo 6
- Los Angeles, CAQorannoo 5
- Macon, GAQorannoo 5
- Lansing, MIQorannoo 5
- Reading, PAQorannoo 5
- Philadelphia, PAQorannoo 4
- Houston, TXQorannoo 4
- Baltimore, MDQorannoo 4
- Farmington Hills, MIQorannoo 4
- Boulder, COQorannoo 4
- Staten Island, NYQorannoo 4
- Dallas, TXQorannoo 4
- Colorado Springs, COQorannoo 4
- Brooklyn, NYQorannoo 3
- Chicago, ILQorannoo 3
- Phoenix, AZQorannoo 3
- St. Louis, MOQorannoo 3
- Kansas City, KSQorannoo 3
- Madison, WIQorannoo 3
- Columbus, OHQorannoo 3
- Sterling Heights, MIQorannoo 3
Naannoon
- AlabamaQorannoo 7
- ArizonaQorannoo 6
- CaliforniaQorannoo 8
- ColoradoQorannoo 7
- FloridaQorannoo 9
- GeorgiaQorannoo 10
- IllinoisQorannoo 4
- KansasQorannoo 3
- MarylandQorannoo 4
- MassachusettsQorannoo 4
- MichiganQorannoo 7
- MissouriQorannoo 4
- NevadaQorannoo 3
- New JerseyQorannoo 5
- New YorkQorannoo 4
- North CarolinaQorannoo 9
- OhioQorannoo 10
- PennsylvaniaQorannoo 6
- South CarolinaQorannoo 9
- TexasQorannoo 10
- WisconsinQorannoo 4
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07598708A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07500090A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07455383A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07502443A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07540364A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07540897A Study of Pitolisant in Patients With Prader-Willi Syndrome
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 6 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT06366464A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06767683Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT07484217Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT06568367Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 09-Wax-2026 · NCT06170970Impact of Bright Light Therapy on Prader-Willi Syndrome
Namoota walitti qabaa jira
Umuriin 6 hanga 88 · Saalaa hunda · Haaromfame 15-Cam-2026 · NCT05939453A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT07096674A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 24-Mud-2025 · NCT07082829Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 29-Cam-2025 · NCT01793168Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.